Á lódáil...
A Phase II Study of Gefitinib in Patients with Metastatic Melanoma
BACKGROUND: Gefitinib is an inhibitor of the epidermal growth factor receptor, which is frequently expressed on both choroidal and non-choroidal melanoma cells. We evaluated the clinical efficacy of gefitinib in patients with metastatic melanoma. METHODS: Patients with stage IV or unresectable stage...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
2011
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3132394/ https://ncbi.nlm.nih.gov/pubmed/21738104 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CMR.0b013e3283471073 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|